Paradigm Biocapital Advisors LP

SEC CIK: 0001855655
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

ENTA holding history

Enanta Pharmaceuticals Inc in every 13F filed by Paradigm Biocapital Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENTA overview All 13F holders of ENTA Full Q2 2026 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2021

Holdings of ENTA by Paradigm Biocapital Advisors LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−148,216−100.0%	Sold out	Holders
Q2 2022	148,216	$7.01M	1.4%	+148,216	New	Holders
Q1 2022	0	$0	0.0%	−75,507−100.0%	Sold out	Holders
Q4 2021	75,507	$5.65M	1.6%	–	No prior filing	Holders